Author
The author works as a Correspondent with BW Businessworld
In an exclusive interaction with BW Healthcare World, RK Baheti, CFO, Alembic Pharmaceuticals speaks on the headwinds for generics, the progress of PLI schemes in pharma, updates on the USFDA inspections, takeaways from the budget and the company's outlook in the upcoming financial year
Read More
Dr Shuchin Bajaj, Founder Director, Ujala Cygnus Hospitals speaks with BW Healthcare World on the evolving scenario of tier 2 and tier 3 cities, maintaining profitability, operating on low costs, leveraging technology and overcoming challenges of delivering healthcare in the towns
Read More
Hyderabad-based Divi’s Laboratories has reported its earnings for the third quarter and has reported a 27.4 per cent slump year on year in its consolidated revenue which stood at Rs 1,822 crores as against total revenue of Rs 2,510 crores during the corresponding quarter of last year
Read More
Alembic Pharma recorded a Profit After Tax (PAT) of Rs 122 crores in quarter three of the financial year 2023 (Q3FY23) against Rs 171 crores recorded in the corresponding quarter of the previous year, a 29 per cent slump year on year
Read More
The overall budget outlay given to the Ministry of Health and Family Welfare has increased by 3.42 per cent against Rs 86,200 crores given in the FY2021-22. While the health research corpus dipped by 6.8 per cent from Rs 3,200 crores in the FY22-23, a contraction of Rs 220 crores
Read More
Glenmark Lifesciences recorded a net profit of Rs 105 crores in quarter three of the financial year 2023(Q3FY23) against Rs 103.7 crores recorded in the corresponding quarter in the previous year, a 1.2 per cent jump year on year while the PAT dropped by 1.2 per cent quarter on quarter
Read More
Dr Reddy's labs, the Indian pharma major headquartered in Hyderabad on Wednesday announced its consolidated financial results for the third quarter that ended 31st December 2022, the pharmaceutical company registered a 27 per cent rise in its consolidated revenues year on year and a 7 per cent jump quarter on quarter in its revenues
Read More
Cipla's net profit also jumped by 10 per cent Year on Year in Q3FY22, the company recorded a net profit of Rs 801 crores in the December quarter. The company saw an increase of Rs 73 crores from the earnings of the same quarter last year which stood at Rs 728 crores
Read More
In an exclusive conversation with BW Healthcare World, Narendra Varde, Managing Director, Roche Diagnostics India & Neighboring Markets speaks on the 2023 trends for the diagnostics industry, the challenges faced by the sector, new products in the pipeline, the roadmap for future challenges and on the power of data analytics
Read More
Strides Pharma reported a net loss of Rs 82 crores in the third quarter, the company said the reported PAT of the company was impacted by loss from JV and associates on account of inventory write-off related to the covid portfolio
Read More
